Geron Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.51

-0.03 (-1.95%)

As of Mar 24, 10:03 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 69%

Hold 3 23%

Sell 1 8%

Price Target

Analyst Price Target +1,158.9% upside

Low Target $12.94

Average Target $19.01

High Target $24.33

Current Price $1.51

Current
$1.51

Target
$19.01

$12.94 $19.01 avg $24.33

Scenario Analysis

Bear Case

$12.94

757.0%

Low target

Base Case

$19.01

+1,158.9%

Avg target

Bull Case

$24.33

+1,511.3%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.66

-43.2% from high

52-Week Low

$1.04

+45.2% from low

Target vs 52W High

$19.01

+614.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%